KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to 1PHIA. 1PHIA was compared to 59 industry peers in the Health Care Equipment & Supplies industry. 1PHIA may be in some trouble as it scores bad on both profitability and health. 1PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
Of the past 5 years 1PHIA 4 years had a positive operating cash flow.
1.2 Ratios
1PHIA has a Return On Assets (1.37%) which is comparable to the rest of the industry.
The Return On Equity of 1PHIA (3.19%) is comparable to the rest of the industry.
1PHIA's Return On Invested Capital of 3.56% is on the low side compared to the rest of the industry. 1PHIA is outperformed by 62.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROIC | 3.56% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.07%, 1PHIA is in line with its industry, outperforming 44.07% of the companies in the same industry.
1PHIA's Operating Margin of 5.39% is on the low side compared to the rest of the industry. 1PHIA is outperformed by 64.41% of its industry peers.
1PHIA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 43.42%, 1PHIA is not doing good in the industry: 69.49% of the companies in the same industry are doing better.
1PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1PHIA is destroying value.
Compared to 1 year ago, 1PHIA has less shares outstanding
1PHIA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1PHIA has a worse debt to assets ratio.
2.2 Solvency
1PHIA has an Altman-Z score of 1.91. This is not the best score and indicates that 1PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
1PHIA has a Altman-Z score (1.91) which is in line with its industry peers.
1PHIA has a Debt/Equity ratio of 0.60. This is a neutral value indicating 1PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, 1PHIA is doing worse than 66.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.91 |
ROIC/WACC0.56
WACC6.4%
2.3 Liquidity
1PHIA has a Current Ratio of 1.28. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.28, 1PHIA is not doing good in the industry: 62.71% of the companies in the same industry are doing better.
1PHIA has a Quick Ratio of 1.28. This is a bad value and indicates that 1PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
1PHIA's Quick ratio of 0.79 is on the low side compared to the rest of the industry. 1PHIA is outperformed by 69.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
1PHIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.45%.
Measured over the past years, 1PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
1PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.89%.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
3.2 Future
Based on estimates for the next years, 1PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.40% on average per year.
Based on estimates for the next years, 1PHIA will show a small growth in Revenue. The Revenue will grow by 3.10% on average per year.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
1PHIA is valuated correctly with a Price/Earnings ratio of 16.59.
1PHIA's Price/Earnings ratio is rather cheap when compared to the industry. 1PHIA is cheaper than 89.83% of the companies in the same industry.
1PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.48.
1PHIA is valuated correctly with a Price/Forward Earnings ratio of 13.29.
1PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1PHIA is cheaper than 79.66% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. 1PHIA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.59 | ||
| Fwd PE | 13.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1PHIA indicates a somewhat cheap valuation: 1PHIA is cheaper than 77.97% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.05 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1PHIA's earnings are expected to grow with 12.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
No dividends for 1PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (8/1/2025, 7:00:00 PM)
22.9
-0.73 (-3.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners42.8%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap22.05B
Analysts73.08
Price Target26.09 (13.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.14%
Min EPS beat(2)-11.97%
Max EPS beat(2)22.24%
EPS beat(4)1
Avg EPS beat(4)-3.31%
Min EPS beat(4)-16.56%
Max EPS beat(4)22.24%
EPS beat(8)2
Avg EPS beat(8)-6.4%
EPS beat(12)4
Avg EPS beat(12)8.51%
EPS beat(16)5
Avg EPS beat(16)1.66%
Revenue beat(2)0
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.17%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.16%
Revenue beat(12)2
Avg Revenue beat(12)-1.77%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-8.75%
PT rev (3m)-9.84%
EPS NQ rev (1m)-6.21%
EPS NQ rev (3m)-25.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)-2.12%
Revenue NQ rev (3m)-5.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.59 | ||
| Fwd PE | 13.29 | ||
| P/S | 1.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.05 |
EPS(TTM)1.38
EY6.03%
EPS(NY)1.72
Fwd EY7.53%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.67
BVpS12.15
TBVpS-1.33
PEG (NY)1.67
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROCE | 4.75% | ||
| ROIC | 3.56% | ||
| ROICexc | 3.78% | ||
| ROICexgc | 11.65% | ||
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% | ||
| FCFM | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.99 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.91 |
F-ScoreN/A
WACC6.4%
ROIC/WACC0.56
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
EBIT growth 1Y379.25%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%